Anaxyl Capsule

About Anaxyl 250 mg Capsule

Anaxyl 250 mg capsules contain tranexamic acid, an anti-fibrinolytic medicine used to help control bleeding in certain medical and surgical conditions. Doctors prescribe it for specific bleeding disorders and situations where clot breakdown needs to be slowed.

There are 35 brands of Tranexamic Acid listed in Bangladesh. The lowest listed price is Enclot 250 mg Capsule at ৳ 8.06 per unit.

What is Anaxyl 250 mg Capsule?

Anaxyl 250 mg capsules contain tranexamic acid, a medicine that helps reduce bleeding by slowing the breakdown of blood clots. It belongs to a group called anti-fibrinolytic drugs. Doctors use it in conditions such as bleeding in the lungs or digestive tract, bleeding linked to leukaemia, cirrhosis or haemophilia, and during surgery or certain treatments. It is also used when bleeding occurs during thrombolytic therapy or transfusion. The dose and course are always set by the doctor based on the individual situation.

Uses of Anaxyl

Anaxyl 250 mg capsules are used to prevent or treat bleeding in a range of situations. These include bleeding in the lungs or digestive tract, bleeding disorders associated with leukaemia, cirrhosis and haemophilia, and a low platelet condition called thrombocytopenic purpura. It is also used during surgery and in bleeding that can happen with thrombolytic therapy or blood transfusion. Your doctor will decide if it is appropriate for you.

How to use Anaxyl

Anaxyl 250 mg capsules are taken by mouth. The dose and how often to take it are decided by the doctor, who will consider your condition and medical history. Do not change the dose or stop taking it without asking the doctor. If you miss a dose, ask your doctor or pharmacist for advice on what to do. Always follow the instructions given by your healthcare professional.

Side effects of Anaxyl

Most people tolerate tranexamic acid well, but some side effects can occur. These include feeling tired, eye irritation, a blocked nose, itching, skin redness or a rash. After taking it by mouth, nausea, diarrhoea or heartburn may happen. Rarely, a drop in blood pressure on standing may occur. If you notice any side effects, especially signs of allergy, stop the medicine and speak to your doctor, who can advise on suitable treatment.

Safety and precautions

Do not take Anaxyl 250 mg capsules if you are allergic to tranexamic acid or if you have a history of blood clots, thrombosis, certain internal bleeding or serious kidney failure. It should not be used during pregnancy unless the doctor decides it is necessary; it passes into breast milk in small amounts. Tell your doctor if you have kidney problems, are taking oral contraceptives or other medicines, or have any bleeding disorder, so they can decide whether it is safe for you.

Frequently asked questions

What kind of medicine is Anaxyl and what is it used for?

Anaxyl 250 mg capsules contain tranexamic acid, an anti-fibrinolytic medicine. It helps reduce bleeding by slowing the breakdown of blood clots. Doctors use it in certain bleeding conditions, during surgery, and in some treatments or transfusions where bleeding may occur.

How should I take Anaxyl capsules?

Take Anaxyl capsules by mouth exactly as your doctor tells you. The dose and how long you take it are decided by the doctor based on your condition. Do not change the dose or stop the medicine without asking your doctor or pharmacist first.

How should I store Anaxyl capsules?

Store Anaxyl capsules in a dry place at room temperature, away from light and out of the reach of children. Do not use them after the expiry date. If you are unsure about storage, ask your pharmacist for advice.

Who should ask a doctor before taking Anaxyl?

Tell your doctor if you are pregnant or breastfeeding, have kidney problems, a history of blood clots, or are taking other medicines such as oral contraceptives. Your doctor will decide whether Anaxyl is suitable for you and will advise on the right dose and course.

Indications

In medicine: Prophylaxis and therapy of hemophtoes, digestive hemorrhages, hemorrhagic syndromes in leukaemia, cirrhosis and hemophilia, thrombocytopenic purpura, accidents during thrombolytic therapy and transfusion.

In surgery: Prophylaxis and antihemorrhagic ... Read moreIn medicine: Prophylaxis and therapy of hemophtoes, digestive hemorrhages, hemorrhagic syndromes in leukaemia, cirrhosis and hemophilia, thrombocytopenic purpura, accidents during thrombolytic therapy and transfusion.

In surgery: Prophylaxis and antihemorrhagic therapy during operations of any type and nature and particularly in pulmonary, cardiovascular and abdominal surgery and post-operative and traumatic shock.

In urology: Prophylaxis and antihemorrhagic therapy of prostatic, vesical and renal surgery. Hematurias.

In obstetrics: Prophylaxis and therapy of post-partum and puerperium hemorrhages, hemorrhagic metrophathies, functional menometrorrhagias, idiopathic or IUD(lntra uterine Device) induced menorrhagias, primitive hyperfibrinolysis (abruptio placentae, premature placenta detachment) and in cervical conization.

In otorhinolaryngology: Prophylaxis and antihemorrhagic therapy during a tonsillectomy, specialist surgery generally, epistaxis.

In stomatology: Prophylaxis and antihemorrhagic therapy during maxillofacial operations, tooth extractions.

In oncology (as supportive therapy): To promote the formation of a fibrin capsule to wall off and thereby inhibit the growth of ovarian tumors. To cause regression of ascites secondary to carcinoma. To reduce bleeding during surgical interventions.

Pharmacology

This is a preparation of tranexamic acid (trans-4 aminomethyl-cyclohexanecarboxylic acid). Tranexamic acid is a substance endowed with a strong antifibrinolytic action and both in vivo and in vitro it has proved to be 10 times more active than conventional hemostatics, depending on the test. The antihemorrhagic action of tranexamic acid is essentially due to an inhibition of the plasminogen activation of both exogenous activators like streptokinase and endogenous ones like urokinase and the plasminogen tissue activator. This fact is particularly important for the clinical use of Tranexamic Acid, because it ensures an antihemorrhagic activity with an antifibrinolytic mechanism under a variety of conditions.

The acute toxicity of Tranexamic Acid is extremely low and chronic toxicity almost non-existent. Tranexamic Acid is well absorbed by oral route and the effect is already seen 15-30 minutes after administration. It is excreted mainly by renal route but more slowly than conventional hemostatics. These features make the Tranexamic Acid effect more lasting than those conventional hemostatics. Considerably lower single doses of Tranexamic Acid can thus be administered at greater intervals without the drug plasma levels dropping to inefficient levels of antifibrinolytic activity between one dose and the other.

Tranexamic Acid at therapeutic doses does not interfere with clotting processes and even a prolonged administration has not been seen to be accompanied by any tendency to thrombophilia.

Dosage & Administration

Adults-
  • The usual dose: 500-1000 mg 3 times daily.
  • For prophylaxis: The mean recommended daily doses are 0.5-1 gm orally, 500 mg by the parenteral (intravenous or intramuscular) route.
  • For therapy of hemorrhagic manifestations: the oral dose increases to 1-3 gm given in divided doses: in cases of particular seriousness and urgency, begin by injecting an ampoule (500 mg) slowly by intravenous route and administer the necessary subsequent oral doses.
Children-
  • For prophylaxis: For every kg of body weight from 5-10 mg are orally administered daily in divided doses.
  • For therapeutic purposes: The oral doses are doubled (from 10 to 20 mg/kg), while the intravenous and intramuscular treatment is begun with 10 mg/kg (=0.5 ml every 5 kg) by the slow intravenous route, continuing the oral administration up to the required dose. Where it is more convenient (e.g. in small babies) the ampoules, diluted in a little sweetened water, maybe orally administered instead of the Capsules.
Elderly patients: No reduction in dosage is necessary unless there is evidence of renal failure.

Interaction

Tranexamic Acid is a synthetic Amino Acid that is incompatible with solutions containing penicillins (eg: Benzyl penicillin). Thrombolytic drugs like Streptokinase & Urokinase antagonise the antifibrinolytic action of Tranexamic Acid. The potential for thrombus formation may be increased by concomitant administration of estrogen containing drugs, like oral contraceptives. Direct admixture of Tranexamic Acid with whole blood should be avoided during Transfusion.

Contraindications

Known individual hypersensitivity to the product. Thromboembolic disease, arterial and venous thrombosis, endocavitary hemorrhages, serious kidney failure.

Side Effects

  • Tranexamic Acid is generally well tolerated; there may be infrequent cases of sense of fatigue, conjunctival irritation, nasal blockage, itching, skin reddening, exanthems.
  • After oral administration there may be sign of nausea, diarrhea, gastric pyrosis.
  • There are rare cases of postural hypotension.
  • In the case of hypersensitivity to tranexamic acid, avoid or suspend treatment and start a suitable therapy.

Pregnancy & Lactation

Since the transplacental passage of the drug and its possible effects on the fetus are unknown, Tranexamic Acid should not be administered during known and presumed pregnancy. Tranexamic Acid passes into breast milk to a concentration of approximately one hundredth of the concentration in the maternal blood. An antifibrinolytic effect in the infant is unlikely.

Precautions & Warnings

  • Tranexamic Acid should be used in cases where there is hyperfibrinolysis. The prophylactic treatment must begin 24 hours before the operation and continue until 3-4 days after it.
  • The therapy of hemorrhages must be prolonged for at least 24 hours after manifestations have disappeared.
  • In hematuria, especially when this is not accompanied by any other hemorrhagic manifestations, reduce the doses to prevent formation of clots in the urinary tract.
  • Tranexamic Acid must not be used in serious renal insufficiency or anuric syndromes and must only be used with caution in less serious renal dysfunctions.
  • The administration of product requires particular care in cardiopathic and hepatopathic subjects.

Storage Conditions

Store in a dry place at 15-30°C, away from light and keep out of children's reach.

Alternative brands of Tranexamic Acid

Other brands with the same generic name, cheapest first.

Anaxyl Capsule

500 mg

Tranexamic Acid

Advanced Chemical Industries PLC

৳ 19.66 ৳ 20.06 2% off per unit

Anaxyl Tablet

500 mg

Tranexamic Acid

Advanced Chemical Industries PLC

৳ 19.66 ৳ 20.06 2% off per unit

See all 35 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.